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Editorial Response: Are all Bartonella henselae Strains Created Equal? 
Of the five Bartonella species associated with disease in 
humans, B. henselae causes the widest spectrum of pathology, 
including disease with granulomatous features (cat-scratch dis- 
ease), vascular proliferative features (bacillary angiomatosis- 
peliosis, BA-BP), and a predominantly intravascular focus 
(bacteremia-endocarditis). In the wake of the initial detection 
of B. henselae and its laboratory propagation in 1990 [1, 2], 
investigators have learned that B. henselae is distributed world- 
wide; that cats are reservoirs for the organism; that fleas are 
vectors for transmission among cats [3, 4]; and that B. henselae, 
like other Bartonella species, establishes an intimate and persis- 
tent relationship within the bloodstream of its hosts. Yet, we 
understand little about the diversity and population structure 
of B. henselae and the genetic basis for its pathogenicity. In 
this regard, the key questions are whether a small number of 
clonal types account for a disproportionate amount of disease, 
whether some clonal types are more likely than others to cause 
a particular type of pathology, whether there is a restricted 
geographic distribution of specific clonal types, and what is the 
possible genetic basis of type-specific differences in virulence. 
See the article by Arvand et al. on pages 1296-9. 
Practical problems often hinder the solution of important 
theoretical questions. In the case of B. henselae, isolation of 
the organism directly from the host is difficult [5], thereby 
limiting the number and diversity of cultivated strains available 
for study. While amplification of the 16S rRNA gene and other 
phylogenetically reliable sequences directly from clinical speci- 
mens offers an alternative to laboratory cultivation, there is no 
standardized, well-accepted genotypic method for identifying 
and defining B. henselae clonal types. At the same time, cultiva- 
tion of strains permits correlation of in vitro phenotype with 
genotype. Thus, the work described by Arvand and colleagues 
[6] represents a valuable contribution, i.e., the first reported 
recovery of a clinical B. henselae isolate from a vascular prolif- 
erative lesion in a European patient. 
What do we know about this B. henselae isolate and its 
relation to others? Arvand et al. relied on pulsed-field gel elec- 
trophoresis (PFGE) of endonuclease-restricted chromosomal 
DNA to establish a "match" between this German isolate, 
Berlin-1, and the Houston-1 type strain, originally isolated from 
the blood of a febrile, HIV-infected individual in Texas [7]. 
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PFGE chromosomal profiles distinguished between these two 
strains and B. henselae ATCC 49793, originally isolated from 
the blood of a febrile patient with AIDS in Oklahoma [2], as 
well as a German feline strain; however, other B. henselae 
strains were not examined in parallel. In fact, PFGE patterns 
have been determined for only a small number of B. henselae 
strains [8]. Thus, it is difficult to compare Berlin-1 with other 
isolates from around the world. Recently, Sander and col- 
leagues [9] isolated 13 B. henselae strains from 100 domestic 
cats in Freiburg, Germany [9]; it would be interesting to include 
these strains in this analysis. 
Two other genotypic methods have been proposed for 
B. henselae strain discrimination: restriction fragment length 
polymorphism (RFLP) analysis of the intergenic transcribed 
spacer (ITS) region within the rRNA operon [10], and repetitive 
element PCR [11]. Each method has revealed moderate strain 
diversity among the small numbers examined so far [12, 13], 
in contrast with even more limited diversity among Bartonella 
quintana strains. 
As B. henselae strain typing databases expand and become 
more standardized, investigators will be able to compare the 
diversity of strains within cat reservoirs with the diversity of 
strains that cause various human clinical syndromes. Early 
studies have revealed a greater number of ITS RFLP strain 
types in the blood of HIV-infected bacteremic patients than in 
the cat-scratch-disease l sions of immunocompetent individu- 
als [10, 12], but the role of confounding variables has not been 
adequately assessed. The possibility that particular B. henselae 
clones or strains are associated with specific clinical syndromes 
still cannot be excluded. The work of Arvand and colleagues 
and other groups will eventually provide data with which hu- 
man-associated and cat-associated isolates can be compared [9, 
14, 15]. It is expected that greater strain diversity will be found 
within the natural reservoir (cats) than within incidental hosts 
(humans). In most instances, the strains associated with human 
disease will also be found in the cats with which these patients 
had direct contact [13]. 
The geographic distribution of strains remains unclear. In- 
complete data indicate that B. henselae is endemic in the United 
States, Europe (France, Germany, Holland, and Denmark), Af- 
rica (Zimbabwe and South Africa), Australia, and Japan. These 
diverse sites provide a rich potential source of genetic data. 
While repetitive element PCR requires the availability of puri- 
fied bacterial isolates, in theory ITS RFLP could be performed 
on cloned genomic fragments amplified directly from clinical 
specimens with broad-range primers directed against conserved 
flanking sequences. 
Where should these investigations lead? First, standardized, 
reliable, and discriminatory strain typing methods are needed 
for B. henselae. In general, such methods should provide quan- 
tifiable measures of evolutionary distance between any two 
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strains, relying on genetically stable markers of genomic ances- 
try. Primary sequence is a useful, quantifiable character. Al- 
though rDNA is a phylogenetically reliable marker, it often 
fails to provide sufficient resolving power at the strain level. 
Other genetic loci such as the rRNA operon ITS will need to 
be evaluated further. 
Second, many of the most important virulence-associated 
genes in microbial pathogens are promiscuous and evolution- 
arily "unstable;" they are shared among strains by means of 
plasmids, transposable elements, and phages. These genes 
need to be targeted separately. However, few virulence-asso- 
ciated genes of B. henselae have been identified. It would be 
expected that the products of such genes subvert host defenses 
mediated by skin dendritic cells and soluble bloodbome fac- 
tors, facilitate penetration of tissue stroma and attachment 
to erythrocytes, elicit angiogenic host cytokines and growth 
factors, and recognize environmental signals within humans, 
cats, and fleas. Powerful strategies to identify these genes take 
advantage of their selective expression within a relevant host 
environment [16]. 
In addition, it is now known that many of these genes in 
general are physically clustered on a plasmid or within a chro- 
mosomal "pathogenicity island" and are acquired in "quantum 
evolutionary leaps" [17, 18]. Might the distribution and com- 
position of pathogenicity islands among extant B. henselae 
clonal populations explain differing associated disease manifes- 
tations? Although there is no evidence to support this specula- 
tion, the methods that have been used to identify B. henselae 
strains are insensitive to pathogenicity island or virulence gene 
polymorphisms. With continued efforts to identify disease-as- 
sociated genes by means of genetic and genomic approaches, 
the population and genomic structure of B. henselae will be- 
come more clear. With full genome sequencing for B. henselae 
under way, it may not be long before B. henselae isolates and 
the corresponding host responses are both characterized and 
compared by using comprehensive DNA microarrays in a semi- 
automated format. 
David A. Relman 
From the Department of Medicine, Veterans Affairs Palo Alto Health 
Care System, Palo Alto, California 
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